New Test Predicts Whether Mild Cognitive Impairment Will Convert To Alzheimer's Disease
Tuesday, March 17, 2009 - 02:43
in Health & Medicine
A test capable of confirming or ruling out Alzheimer's disease has been validated and standardized. By measuring cerebrospinal fluid concentrations of two of the disease's biochemical hallmarks -- amyloid beta42 peptide and tau protein -- the test also predicted whether a person's mild cognitive impairment would convert to Alzheimer's disease over time. The test accurately ruled out Alzheimer's disease in 95.2 percent of the subjects.
Read the whole article on Science Daily
More from Science Daily
Related
- Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's diseaseMon, 16 Mar 2009, 12:30:38 EDT
- Biomarkers may help predict risk of Alzheimer's disease in patients with mild cognitive impairmentTue, 21 Jul 2009, 16:43:42 EDT
- Mayo Clinic study continues to refine most effective methods to predict Alzheimer's diseaseTue, 14 Jul 2009, 9:23:04 EDT
- Memory test and PET scans detect early signs of Alzheimer'sTue, 14 Jul 2009, 3:10:30 EDT
- Alzheimer's disease: Newly found peptide offers hope of early test and better treatmentTue, 9 Jun 2009, 20:37:08 EDT